The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Becton, Dickinson and Co's share price is $255.30.
Becton, Dickinson and Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 was $71.66. Hence, Becton, Dickinson and Co's PS Ratio for today is 3.56.
Good Sign:
Becton, Dickinson and Co stock PS Ratio (=3.57) is close to 5-year low of 3.26
The historical rank and industry rank for Becton, Dickinson and Co's PS Ratio or its related term are showing as below:
BDX'
s PS Ratio Range Over the Past 10 Years
Min: 1.94 Med: 3.24 Max: 4.5
Current: 3.55
During the past 13 years, Becton, Dickinson and Co's highest PS Ratio was 4.50. The lowest was 1.94. And the median was 3.24.
BDX's PS Ratio is ranked better than 55.3% of 792
companies
in the Medical Devices & Instruments industry
Industry Median: 4.39
vs BDX: 3.55
Becton, Dickinson and Co's Revenue per Sharefor the
three
months ended in Jun. 2022 was $16.15.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 was $71.66.
Good Sign:
Becton, Dickinson and Co has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Becton, Dickinson and Co was 7.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 4.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 3.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 7.30% per year.
During the past 13 years, Becton, Dickinson and Co's highest 3-Year average Revenue per Share Growth Rate was 15.30% per year. The lowest was 1.70% per year. And the median was 8.20% per year.
Back to Basics: PS Ratio
Becton, Dickinson and Co PS Ratio Historical Data
The historical data trend for Becton, Dickinson and Co's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Becton, Dickinson and Co Annual Data
Trend
Sep12
Sep13
Sep14
Sep15
Sep16
Sep17
Sep18
Sep19
Sep20
Sep21
PS Ratio
3.53
4.21
3.92
3.74
3.46
Becton, Dickinson and Co Quarterly Data
Sep17
Dec17
Mar18
Jun18
Sep18
Dec18
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
PS Ratio
3.54
3.46
3.47
3.64
3.44
Competitive Comparison
For the Medical Instruments & Supplies subindustry, Becton, Dickinson and Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton, Dickinson and Co PS Ratio Distribution
For the Medical Devices & Instruments industry and Healthcare sector, Becton, Dickinson and Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Becton, Dickinson and Co's PS Ratio falls into.
Becton, Dickinson and Co PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Becton, Dickinson and Co's PS Ratio for today is calculated as
Becton, Dickinson and Co's Share Price of today is $255.30.
Becton, Dickinson and Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $71.66.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Becton, Dickinson and Co (NYSE:BDX) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Becton, Dickinson and Co PS Ratio Related Terms
Thank you for viewing the detailed overview of Becton, Dickinson and Co's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
Premium Gurus 
0.67(0.26%) Volume: 1,126,874 4:00PM EDT
Email Alerts
Stock PDF
RSS
Website
Filings
Download
Manual of Stocks™ Web APP
NYSE:BDX has been successfully added to your 
